Genix Pharmaceuticals Corp
XTSX:GENX
Genix Pharmaceuticals Corp
EPS (Diluted)
Genix Pharmaceuticals Corp
EPS (Diluted) Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Genix Pharmaceuticals Corp
XTSX:GENX
|
EPS (Diluted)
CA$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Flora Growth Corp
NASDAQ:FLGC
|
EPS (Diluted)
-$50
|
CAGR 3-Years
49%
|
CAGR 5-Years
1%
|
CAGR 10-Years
N/A
|
|
|
Vitality Products Inc
XTSX:VPI
|
EPS (Diluted)
CA$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Jamieson Wellness Inc
TSX:JWEL
|
EPS (Diluted)
CA$1
|
CAGR 3-Years
6%
|
CAGR 5-Years
9%
|
CAGR 10-Years
N/A
|
|
|
L
|
Leef Brands Inc
CNSX:LEEF
|
EPS (Diluted)
$0
|
CAGR 3-Years
-122%
|
CAGR 5-Years
-41%
|
CAGR 10-Years
N/A
|
|
Genix Pharmaceuticals Corp
Glance View
Genix Pharmaceuticals Corp. engages in the the research, development, manufacture, licensing and sales of novel and innovative healthcare products, particularly proprietary over the counter nutraceuticals and generic pharmaceuticals. The company is headquartered in Vancouver, British Columbia. The firm focused on developing and licensing novels and products for sales through retail outlets and well as direct to consumers and e-commerce platforms. The firm holds licensing agreement for a range of products, including 30 Ophthalmic drugs, Sucanon, Renochlor, Flu-X, and Levothyroxine sodium (generic Synthroid). Flu-X anti-viral spray is an herbal, oral, anti-viral, anti-flu and anti-cold virus spray. Renochlor is an aid in the restoration of kidney health and kidney function. Sucanon is a natural substitute for prescription pharmaceuticals for non-insulin dependent diabetes patients.
See Also
What is Genix Pharmaceuticals Corp's EPS (Diluted)?
EPS (Diluted)
0
CAD
Based on the financial report for Jul 31, 2025, Genix Pharmaceuticals Corp's EPS (Diluted) amounts to 0 CAD.
